Role of microglia in glioma biology
暂无分享,去创建一个
[1] B. Badie,et al. Expression of Fas ligand by microglia: possible role in glioma immune evasion , 2001, Journal of Neuroimmunology.
[2] Becky,et al. Dexamethasone-induced abolition of the inflammatory response in an experimental glioma model: a flow cytometry study. , 2000, Journal of neurosurgery.
[3] I. Parney,et al. Human glioma immunobiology in vitro: implications for immunogene therapy. , 2000, Neurosurgery.
[4] B. Badie,et al. Interferon-γ Induces Apoptosis and Augments the Expression of Fas and Fas Ligand by Microglia in Vitro , 2000, Experimental Neurology.
[5] B. Badie,et al. Flow cytometric characterization of tumor-associated macrophages in experimental gliomas. , 2000, Neurosurgery.
[6] R. Dempsey,et al. Traumatic Brain Injury Leads to Increased Expression of Peripheral-Type Benzodiazepine Receptors, Neuronal Death, and Activation of Astrocytes and Microglia in Rat Thalamus , 2000, Experimental Neurology.
[7] M. Graeber,et al. Microglia only weakly present glioma antigen to cytotoxic T cells , 1999, International Journal of Developmental Neuroscience.
[8] P. Rieckmann,et al. Microglial/macrophage expression of interleukin 10 in human glioblastomas , 1999, International journal of cancer.
[9] I. Bechmann,et al. FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: Evidence for the existence of an immunological brain barrier , 1999, Glia.
[10] K. Frei,et al. Treatment of experimental glioma by administration of adenoviral vectors expressing Fas ligand. , 1999, Human gene therapy.
[11] B. Badie,et al. In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor. , 1999, Neurosurgery.
[12] V. Nguyen,et al. Class II transactivator and class II MHC gene expression in microglia: modulation by the cytokines TGF‐β, IL‐4, IL‐13 and IL‐10 , 1999, European journal of immunology.
[13] D. Wedekind,et al. Tumor gene therapy made easy: allogeneic major histocompatibility complex in the C6 rat glioma model. , 1999, Human gene therapy.
[14] Charles B. Wilson,et al. Primary central nervous system tumors: Advances in knowledge and treatment , 1998, CA: a cancer journal for clinicians.
[15] Imai,et al. Differential expression of MHC class II molecules by microglia and neoplastic astroglia: relevance for the escape of astrocytoma cells from immune surveillance , 1998, Neuropathology and applied neurobiology.
[16] J. Sedgwick,et al. Central nervous system microglial cell activation and proliferation follows direct interaction with tissue-infiltrating T cell blasts. , 1998, Journal of immunology.
[17] E. Hudson,et al. Met and hepatocyte growth factor/scatter factor expression in human gliomas. , 1997, Cancer research.
[18] S. Leung,et al. Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas , 1997, Acta Neuropathologica.
[19] Erwin G. Van Meir,et al. Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? , 1997, The Journal of clinical investigation.
[20] J. Sedgwick,et al. Microglia induce CD4 T lymphocyte final effector function and death , 1996, The Journal of experimental medicine.
[21] W. Paulus,et al. Distribution and characterization of microglia/macrophages in human brain tumors , 1996, Acta Neuropathologica.
[22] S. Thanos,et al. The concept of microglia in relation to central nervous system disease and regeneration , 1996, Progress in Neurobiology.
[23] T. Tsukahara,et al. Hepatocyte growth factor specifically expressed in microglia activated Ras in the neurons, similar to the action of neurotrophic factors. , 1995, Biochemical and biophysical research communications.
[24] D. Dickson,et al. GM‐CSF promotes proliferation of human fetal and adult microglia in primary cultures , 1994, Glia.
[25] Erwin G. Van Meir,et al. Human astrocytomas and glioblastomas express monocyte chemoattractant protein‐1 (MCP‐1) in vivo and in vitro , 1994, International journal of cancer.
[26] Streit Wj. Cellular immune response in brain tumors. , 1994 .
[27] P. Mcgeer,et al. Immunohistochemistry with antibodies to hepatocyte growth factor and its receptor protein (c-MET) in human brain tissues , 1994, Brain Research.
[28] I. Kuchna,et al. Reaction of microglial cells in human astrocytomas (preliminary report). , 1994, Folia neuropathologica.
[29] K. Jaeckle. Immunotherapy of malignant gliomas. , 1994, Seminars in oncology.
[30] T. Marunouchi,et al. Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro. , 1993, Journal of immunology.
[31] D. Walker,et al. Microglia in degenerative neurological disease , 1993, Glia.
[32] E. Ling,et al. The origin and nature of ramified and amoeboid microglia: A historical review and current concepts , 1993, Glia.
[33] P. Comoglio,et al. Selective expression of the Met/HGF receptor in human central nervous system microglia. , 1993, Oncogene.
[34] K. Black,et al. Inflammatory cell infiltrates vary in experimental primary and metastatic brain tumors. , 1992, Neurosurgery.
[35] Erwin G. Van Meir,et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) production by glioblastoma cells. Despite the presence of inducing signals GM-CSF is not expressed in vivo. , 1992, Journal of immunology.
[36] V. ter meulen,et al. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[37] J. Merrill,et al. Natural and induced cytotoxicity of oligodendrocytes by microglia is inhibitable by TGFβ , 1991, Glia.
[38] J. Kuratsu,et al. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants , 1989, The Journal of experimental medicine.
[39] C C Chang,et al. Immunohistological evaluation of macrophage infiltrates in brain tumors. Correlation with peritumoral edema. , 1988, Journal of neurosurgery.
[40] K. Frei,et al. Antigen presentation and tumor cytotoxicity by interferon‐γ‐treated microglial cells , 1987 .
[41] S. Green,et al. Glioblastoma multiforme and anaplastic astrocytoma pathologic criteria and prognostic implications , 1985, Cancer.
[42] K. Gollahon,et al. Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors. , 1979, Journal of neurosurgery.
[43] K. Gollahon,et al. Macrophages in experimental and human brain tumors. Part 1: Studies of the macrophage content of experimental rat brain tumors of varying immunogenicity. , 1979, Journal of neurosurgery.
[44] W. Markesbery,et al. Relationship of lymphocyte invasion and survival of brain tumor patients , 1978, Annals of neurology.